PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Return
33.7%
This Quarter Return
+6.59%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$864M
AUM Growth
+$21.2M
(+2.5%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
2.21%
Top 10 Holdings %
Top 10 Hldgs %
32.42%
Holding
103
New
11
Increased
47
Reduced
28
Closed
15
Top Buys
| 1 |
IQVIA
IQV
|
+$17.3M |
| 2 |
GeneDx Holdings
WGS
|
+$16.2M |
| 3 |
Danaher
DHR
|
+$9.25M |
| 4 |
DexCom
DXCM
|
+$8.34M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$7.63M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
+$27.6M |
| 2 |
UnitedHealth
UNH
|
+$26.3M |
| 3 |
Stryker
SYK
|
+$10.8M |
| 4 |
Gilead Sciences
GILD
|
+$9.68M |
| 5 |
Tenet Healthcare
THC
|
+$7.84M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
SI-BONE Inc
SIBN
$685M
| $6.81M | 0.78% |
362,008
+130,899
| +57% | +$2.46M |
|
52
Mineralys Therapeutics
MLYS
$2.94B
| $6.27M | 0.72% |
463,601
+169,673
| +58% | +$2.3M |
|
53
uniQure
QURE
$943M
| $6.18M | 0.71% |
443,422
+239,589
| +118% | +$3.34M |
|
54
Artivion
AORT
$1.96B
| $5.99M | 0.69% |
192,705
+81,053
| +73% | +$2.52M |
|
55
Veracyte
VCYT
$2.52B
| $5.96M | 0.68% |
220,387
+54,109
| +33% | +$1.46M |
|
56
Certara
CERT
$1.71B
| $5.85M | 0.67% |
+500,000
| New | +$5.85M |
|
|
WAY
57
Waystar Holding Corp
WAY
$6.74B
| $5.72M | 0.66% |
+140,000
| New | +$5.72M |
|
58
Ultragenyx Pharmaceutical
RARE
$2.98B
| $5.38M | 0.62% |
147,980
-156,264
| -51% | -$5.68M |
|
59
Incyte
INCY
$16.9B
| $5.11M | 0.59% |
+75,000
| New | +$5.11M |
|
60
Treace Medical Concepts
TMCI
$457M
| $4.96M | 0.57% |
843,998
+130,459
| +18% | +$767K |
|
61
Arcus Biosciences
RCUS
$1.25B
| $4.88M | 0.56% |
599,610
-616,019
| -51% | -$5.01M |
|
|
PHLT
62
Performant Healthcare, Inc. Common Stock
PHLT
$608M
| $4.86M | 0.56% |
1,214,272
+153,671
| +14% | +$615K |
|
63
Xenon Pharmaceuticals
XENE
$2.86B
| $4.71M | 0.54% |
150,373
-24,203
| -14% | -$758K |
|
64
CVRx
CVRX
$216M
| $4.64M | 0.53% |
789,099
-440,423
| -36% | -$2.59M |
|
65
Amylyx Pharmaceuticals
AMLX
$1.05B
| $4.17M | 0.48% |
+650,000
| New | +$4.17M |
|
66
Amicus Therapeutics
FOLD
$2.45B
| $3.49M | 0.4% |
608,637
+39,685
| +7% | +$227K |
|
67
Quanterix
QTRX
$209M
| $3.43M | 0.39% |
+515,992
| New | +$3.43M |
|
68
Protagonist Therapeutics
PTGX
$3.63B
| $3.4M | 0.39% |
+61,596
| New | +$3.4M |
|
69
Day One Biopharmaceuticals
DAWN
$747M
| $3.25M | 0.37% |
500,000
-543,162
| -52% | -$3.53M |
|
70
Rapid Micro Biosystems
RPID
$137M
| $3.15M | 0.36% |
913,443
+177,822
| +24% | +$613K |
|
71
Terns Pharmaceuticals
TERN
$657M
| $3.05M | 0.35% |
817,808
-141,895
| -15% | -$529K |
|
72
InspireMD
NSPR
$100M
| $2.8M | 0.32% |
1,235,305
+63,889
| +5% | +$145K |
|
73
Vera Therapeutics
VERA
$1.56B
| $2.74M | 0.32% |
116,343
+40,218
| +53% | +$948K |
|
74
Dynavax Technologies
DVAX
$1.13B
| $2.68M | 0.31% |
270,131
+35,347
| +15% | +$351K |
|
75
Nurix Therapeutics
NRIX
$696M
| $2.6M | 0.3% |
228,271
-122,149
| -35% | -$1.39M |
|